Home / Cancer
Cancer
| 6 min read
Larkspur Biosciences scientists develop drugs that make colorectal cancer tumors vulnerable to killing by the immune system and cell death pathways.
Researchers are finding creative ways to make cell therapies safer and more effective.
| 5 min read
IO Biotech’s two-pronged cancer vaccine targets tumors and the suppressive immune cells around them, demonstrating promising results in metastatic melanoma.
| 3 min read
Backed by patient data and an AI platform, the BPGbio team presented promising results for a mitochondrial-targeted therapy in glioblastoma at AACR 2025.
| 4 min read
Cancer researchers in biotech and pharma highlight the clinical trials and developments they’re most excited about.
| 5 min read
Among the thrill of new results presented at the AACR 2025 conference, the specter of funding cuts to cancer research hung over the meeting.
Integrating multiplexed immunohistochemistry with spatial analysis offers a practical way to uncover tumor-immune dynamics.
| 2 min read
Collaboration to leverage Oxford Nanopore’s sequencing platform and Cepheid’s GeneXpert system to advance the field of sequencing for infectious diseases.
| 4 min read
Planned acquisition will strengthen the presence of the Healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and expand reach of SpringWorks' therapeutic innovations to more patients with rare tumors worldwide
| 1 min read
ProBioGen announced the commercial launch of Ziihera®, a bispecific antibody for HER2-positive biliary tract cancer developed with its GlymaxX® technology.
| 2 min read
Autophagy in cancer is a double-edged sword: It protects cells from malignant transformation, but once tumors form, it helps them thrive.
| 7 min read
A targeted interleukin-12 gene therapy plus chemotherapy increased survival in advanced ovarian cancer, setting the stage for a new first-line drug.
